MAPT and Alzheimer disease: This allows us to probe each aspect of the AD cascade and estimate which groups are likely to have higher downstream pathology for a given level of upstream pathology (i.e. if a population has greater EC tau for a given level of Aβ and how this may result in higher levels of MetaTemp tau).